 |
Recombinant anti-CD-40 monoclonal antibody |
|---|---|
| Trade Name | |
| Orphan Indication | Multiple myeloma |
| USA Market Approval | USA |
| USA Designation Date | 2006-01-25 00:00:00 |
| Sponsor | Novartis Pharmaceutical Corporation;Oncology Business Unit, One Health Plaza, Bldg 104;East Hanover, New Jersey, 07936 |
Related Access Program
AbbVie – Multiple Myeloma
Janssen Research & Development, LLC – Multiple Myeloma
Dana-Farber Cancer Institute – Multiple Myeloma
Bristol-Myers Squibb – Multiple Myeloma
Peking University – Multiple Myeloma
Novartis Pharmaceuticals – Multiple Myeloma
Onyx Pharmaceuticals, Inc., an Amgen subsidiary – Multiple myeloma